Results 111 to 120 of about 14,579 (261)

Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy

open access: yes, 2022
The clinical course for patients with neuroendocrine neoplasms (NENs) ranges from indolent to highly aggressive. Non-invasive tools to improve prognostication and guide decisions on treatment are warranted.
Loft, Annika   +6 more
core   +1 more source

table s1 from Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer

open access: gold, 2023
Yuqi Jing   +7 more
openalex   +1 more source

uPAR is not required for skeletal muscle regeneration

open access: yesThe FASEB Journal, 2006
Muscle regeneration has been shown to be severely impaired in urokinase‐type plasminogen activator deficient (uPA‐/‐) mice, and the impaired regeneration was associated with a lack of macrophage accumulation following muscle injury. Many studies have demonstrated that the receptor for uPA (uPAR) plays an important role in inflammatory cell migration ...
Scott C Bryer, Timothy J Koh
openaire   +1 more source

Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy

open access: yesEJNMMI Research
Background Treatment of patients with low-grade and high-grade gliomas is highly variable due to the large difference in survival expectancy. New non-invasive tools are needed for risk stratification prior to treatment.
Aleena Azam   +7 more
doaj   +1 more source

Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells

open access: yesBMC Cancer, 2010
Background uPAR and MMP-9, which play critical roles in tumor cell invasion, migration and angiogenesis, have been shown to be associated with lipid rafts.
Estes Norman   +5 more
doaj   +1 more source

Cytoplasmic and membrane staining of uPAR.

open access: yes, 2014
Representative photomicrographs of tissue microarray sections stained for uPAR, showing typical A) membrane and B) cytoplasmic localized staining of the tumour cells. Scalebar = 50 µm.
Lars Uhlin-Hansen (350451)   +5 more
core   +1 more source

Data from Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals

open access: gold, 2023
Anne Langkilde   +7 more
openalex   +1 more source

Urokinase-Rezeptor (uPAR) und Zellkontakte : Mechanismen uPAR-abhängiger Zelladhäsion, Zellmigration und Signaltransduktion

open access: yes, 2009
Das uPA (Urokinase)-/ uPAR (Urokinaserezeptor)- System ist primär als Fibrinolysesystem bekannt, stellt jedoch zusätzlich ein multifunktionelles System mit einem breitem Einflussspektrum auf inflammatorische Prozesse, Gefäßerkrankungen und Karzinomleiden dar.
Petzinger, Jutta   +1 more
openaire   +2 more sources

Ultrastructural visualization of uPAR endocytic vesicles.

open access: yes, 2013
HEK293-uPAR cells were incubated with anti-uPAR monoclonal antibody R3 (that recognizes the D1 extracellular domain) at 4°C for 20 minutes, washed and then probed with protein A gold 10 nm in the absence and in the presence of 200 nM RAP. After extensive
Francesco Blasi (61418)   +4 more
core   +1 more source

Urokinase Receptor and Resistance to Targeted Anticancer Agents

open access: yesFrontiers in Pharmacology, 2015
The urokinase receptor/uPAR is a GPI-anchored membrane protein, which regulates protease activity at the cell surface and, in collaboration with a system of co-receptors, triggers cell-signaling and regulates gene expression within the cell.
Steven L. Gonias, Jingjing eHu
doaj   +1 more source

Home - About - Disclaimer - Privacy